Search details
1.
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with non-alcoholic fatty liver disease: A prospective randomized study.
Diabetes Obes Metab
; 25(6): 1576-1588, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36749298
2.
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study.
Diabetes Obes Metab
; 25(8): 2131-2141, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37046361
3.
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.
Cardiovasc Diabetol
; 20(1): 32, 2021 02 02.
Article
in English
| MEDLINE | ID: mdl-33530982
4.
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
Cardiovasc Diabetol
; 19(1): 1, 2020 01 07.
Article
in English
| MEDLINE | ID: mdl-31910850
5.
Efficacy of intermittent empagliflozin supplementation on dietary self-management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24-week randomized controlled trial.
Diabetes Obes Metab
; 21(2): 303-311, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30187632
6.
Whole hepatic lipid volume quantification and color mapping by multi-slice and multi-point magnetic resonance imaging.
Hepatol Res
; 49(12): 1374-1385, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31313870
7.
Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice.
Am J Physiol Endocrinol Metab
; 315(5): E848-E858, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-29989853
8.
Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study.
Cardiovasc Diabetol
; 17(1): 86, 2018 06 12.
Article
in English
| MEDLINE | ID: mdl-29895330
9.
Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.
Proc Natl Acad Sci U S A
; 112(4): 1143-8, 2015 Jan 27.
Article
in English
| MEDLINE | ID: mdl-25564660
10.
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.
Cardiovasc Diabetol
; 16(1): 84, 2017 07 06.
Article
in English
| MEDLINE | ID: mdl-28683796
11.
A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
Endocr J
; 63(2): 193-8, 2016.
Article
in English
| MEDLINE | ID: mdl-26765270
12.
Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial.
Endocr J
; 63(12): 1087-1098, 2016 Dec 30.
Article
in English
| MEDLINE | ID: mdl-27647480
13.
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.
Proc Natl Acad Sci U S A
; 110(5): 1869-74, 2013 Jan 29.
Article
in English
| MEDLINE | ID: mdl-23302688
14.
Targeting steroid receptor coactivator 1 with antisense oligonucleotides increases insulin-stimulated skeletal muscle glucose uptake in chow-fed and high-fat-fed male rats.
Am J Physiol Endocrinol Metab
; 307(9): E773-83, 2014 Nov 01.
Article
in English
| MEDLINE | ID: mdl-25159329
15.
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats.
Hepatology
; 57(5): 1763-72, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23175050
16.
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.
Proc Natl Acad Sci U S A
; 108(39): 16381-5, 2011 Sep 27.
Article
in English
| MEDLINE | ID: mdl-21930939
17.
Thyroid hormone receptor-ß agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways.
Am J Physiol Endocrinol Metab
; 305(1): E89-100, 2013 Jul 01.
Article
in English
| MEDLINE | ID: mdl-23651850
18.
Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background.
Diabetol Int
; 13(1): 142-147, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-35059250
19.
Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial.
J Diabetes Investig
; 12(10): 1816-1826, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33650779
20.
Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia.
Diabetes Res Clin Pract
; 169: 108412, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32911037